The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Morpholino Antisense Oligomers: Design, Preparation, and Properties
Abstract
Antisense promised major advances in treating a broad range of intractable diseases, but in recent years progress has been stymied by technical problems, most notably inadequate specificity, ineffective delivery into the proper subcellular compartment, and unpredictable activity within cells. Herein is an overview of the design, preparation, and properties of Morpholino oligos, a novel antisense structural type that solves the sequence specificity problem and provides high and predictable activity in cells. Morpholino oligos also exhibit little or no nonantisense activity, afford good water solubility, are immune to nucleases, and are designed to have low production costs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zamecnik, P. C., & Stephenson, M. L. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.1.280 · Cited by 1,792
Antisense Oligonucleotides as Therapeutic Agents—Is the Bullet Really Magical?
Stein, C. A., & Cheng, Y.-C. (1993) · Science · doi:10.1126/science.8351515 · Cited by 1,303
Peptide nucleic acids (PNA). Oligonucleotide analogs with an achiral peptide backbone
Egholm, M., Buchardt, O., Nielsen, P. E., & Berg, R. H. (1992) · Journal of the American Chemical Society · doi:10.1021/ja00031a062 · Cited by 738
Role of RNase H in hybrid-arrested translation by antisense oligonucleotides.
Walder, R. Y., & Walder, J. A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5011 · Cited by 450
Antisense Gene Inhibition by Oligonucleotides Containing C-5 Propyne Pyrimidines
Wagner, R. W., Matteucci, M. D., Lewis, J. G., Gutierrez, A. J., Moulds, C., & Froehler, B. C. (1993) · Science · doi:10.1126/science.7684856 · Cited by 405
Resistance of Morpholino Phosphorodiamidate Oligomers to Enzymatic Degradation
HUDZIAK, R. M., BAROFSKY, E., BAROFSKY, D. F., WELLER, D. L., HUANG, S.-B., & WELLER, D. D. (1996) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.1996.6.267 · Cited by 275
Self-citationHoke, G. D., Draper, K., Freier, S. M., Gonzalez, C., Driver, V. B., Zounes, M. C., & Ecker, D. J. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.20.5743 · Cited by 248
Comparative inhibition of rabbit globin mRNA translation by modified antisense oligodeoxynucleotides
Cazenave, C., Stein, C. A., Loreau, N., Thuong, N. T., Neckers, L. M., Subasinghe, C., Hélène, C., Cohen, J. S., & Toulmé, J.-J. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.11.4255 · Cited by 238
Oligodeoxynucleotides as Antisense Inhibitors of Gene Expression
(1992) · Progress in Nucleic Acid Research and Molecular Biology · doi:10.1016/s0079-6603(08)60574-7 · Cited by 233
Morpholino and Phosphorothioate Antisense Oligomers Compared in Cell-Free and In-Cell Systems
SUMMERTON, J., STEIN, D., HUANG, S. B., MATTHEWS, P., WELLER, D., & PARTRIDGE, M. (1997) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.1997.7.63 · Cited by 179
Self-citationShoji, Y., Akhtar, S., Periasamy, A., Herman, B., & Juliano, R. L. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.20.5543 · Cited by 178
An assessment of the antisense properties of RNase H-competent and steric-blocking oligomers
Bonham, M. A., Brown, S., Boyd, A. L., Brown, P. H., Bruckenstein, D. A., Hanvey, J. C., Thomson, S. A., Pipe, A., Hassman, F., Bisi, J. E., et al. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.7.1197 · Cited by 171
Belikova, A. M., Zarytova, V. F., & Grineva, N. I. (1967) · Tetrahedron Letters · doi:10.1016/s0040-4039(01)89794-x · Cited by 166
Cazenave, C., Loreau, N., Thuong, N. T., Toulmé, J.-J., & Hélène, C. (1987) · Nucleic Acids Research · doi:10.1093/nar/15.12.4717 · Cited by 162
Tonkinson, J. L., & Stein, C. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.20.4268 · Cited by 136
Phosphorothioate Oligodeoxynucleotides: Antisense or Anti-Protein?
Krieg, A. Μ., & Stein, C. (1995) · Antisense Research and Development · doi:10.1089/ard.1995.5.241 · Cited by 127
Comparative evaluation of seven oligonucleotide analogs as potential antisense agents
Morvan, F., Porumb, H., Degols, G., et al. (1993) · Journal of Medicinal Chemistry · doi:10.1021/jm00054a013 · Cited by 116
Stirchak, E. P., Summerton, J. E., & Weller, D. D. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.15.6129 · Cited by 115
Self-citationPhosphoramidate analogues of DNA: synthesis and thermal stability of heteroduplexes
Froehler, B. C., Ng, P. G., & Matteucci, M. D. (1988) · Nucleic Acids Research · doi:10.1093/nar/16.11.4831 · Cited by 110
Efficacy of Morpholino-modified Antisense Oligomers Directed against Tumor Necrosis Factor-α mRNA
Taylor, M. F., Paulauskis, J. D., Weller, D. D., & Kobzik, L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.29.17445 · Cited by 63
Self-citation
Cited by
Effective targeted gene ‘knockdown’ in zebrafish
Nasevicius, A., & Ekker, S. C. (2000) · Nature Genetics · doi:10.1038/79951 · Cited by 2,483
Non-coding RNAs in Development and Disease: Background, Mechanisms, and Therapeutic Approaches
Beermann, J., Piccoli, M.-T., Viereck, J., & Thum, T. (2016) · Physiological Reviews · doi:10.1152/physrev.00041.2015 · Cited by 1,726
Therapeutic siRNA: state of the art
Hu, B., Zhong, L., Weng, Y., Peng, L., Huang, Y., Zhao, Y., & Liang, X.-J. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0207-x · Cited by 1,586
Zebrafish as a Model Vertebrate for Investigating Chemical Toxicity
Hill, A. J., Teraoka, H., Heideman, W., & Peterson, R. E. (2005) · Toxicological Sciences · doi:10.1093/toxsci/kfi110 · Cited by 1,374
Overcoming cellular barriers for RNA therapeutics
Dowdy, S. F. (2017) · Nature Biotechnology · doi:10.1038/nbt.3802 · Cited by 1,139
Metadata
- Authors
- SUMMERTON, J., & WELLER, D.
- Venue
- Antisense and Nucleic Acid Drug Development
- Publisher
- SAGE Publications
- Published
- 1997-06
- Volume
- 7
- Issue
- 3
- Pages
- 187-195
- ISSN
- 1087-2906 (ISSN-L)
- OpenAlex
- W2071230707
- Cited by
- 1,116
- References
- 20
- FWCI
- 3.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.